it reviews the steps of biomarker development, highlights the key issues in successful validation and implementation, and overviews representative examples in the oncology field. Regulatory issues and future perspectives in the era of big data analysis and precision medicine are discussed.
View this resource Bookmark this resource
is
The Innovation Management Toolbox was originally developed through funding from the EJP RD project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825575.
The continued development and maintenance of the Toolbox are now supported by the ERDERA partnership, funded under the European Union’s Horizon Europe Research & Innovation programme, grant agreement No. 101156595.